Immune-related adverse events and the balancing act of immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35046403.
- Also identified by DOI 10.1038/s41467-022-27960-2 and PMC identifier 8770784.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The benefit from immune checkpoint inhibitors is tempered by immunologic toxicities, which involve diverse organs, have varying biology, onset time, and severity. Herein, we identify important areas of controversy and open research questions in the field of immune-related toxicity.
Medical subject headings
- Immunotherapy
- Neoplasms